Nov 2018

WORLD-FIRST MEDICINAL CANNABIS TRIAL TO TREAT BRAIN CANCER

A new world-first trial will examine whether oral medicinal cannabis can affect tumour growth in patients with glioma, a common type of brain cancer. As well as supporting the standard treatment for a brain tumour, researchers also hope that medicinal cannabis will have a positive impact on patient’s quality of life. Read the article here.

In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.

READ MORE >

In an exclusive interview with 60 Minutes, Olivia Newton-John, Australian actress who is recovering from her third breast cancer continues to credit medical cannabis with helping her manage not only the pain, but also sleep and anxiety.

READ MORE >

We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >